(Q50575493)

15 March 2018

title

Pegylated interferon alpha-2b as monotherapy or in combination with ribavirin in chronic hepatitis delta. (English)

1 reference

15 March 2018

1 reference

1 reference

1 reference

1

1 reference

15 March 2018

Giuseppina Brancaccio

9

1 reference

15 March 2018

Rosanna Fontana

10

1 reference

15 March 2018

Angelo Andriulli

12

1 reference

15 March 2018

Maria Stanzione

object named as

Maria Stanzione

7

0 references

Antonina Smedile

4

object named as

Antonina Smedile

1 reference

15 March 2018

Mario Rizzetto

13

object named as

Mario Rizzetto

1 reference

15 March 2018

author name string

Alessia Ciancio

2

1 reference

15 March 2018

Giovanni Battista Gaeta

3

1 reference

15 March 2018

Aldo Marrone

5

1 reference

15 March 2018

Antonella Olivero

6

1 reference

15 March 2018

Ezio David

8

1 reference

15 March 2018

Francesco Perri

11

1 reference

15 March 2018

language of work or name

English

0 references

publication date

1 September 2006

1 reference

15 March 2018

published in

Hepatology

1 reference

15 March 2018

volume

44

1 reference

15 March 2018

issue

3

1 reference

15 March 2018

page(s)

713-720

1 reference

15 March 2018

Significance of IgM anti-hepatitis D virus (HDV) in chronic HDV infection

cites work

1 reference

7 January 2021

Changing pattern of chronic hepatitis D in Southern Europe

1 reference

7 January 2021

Chronic hepatitis D: a vanishing Disease? An Italian multicenter study

1 reference

7 January 2021

Treatment of chronic hepatitis D with interferon alfa-2a

1 reference

7 January 2021

Resolution of chronic delta hepatitis after 12 years of interferon alfa therapy

1 reference

7 January 2021

Long-term benefit of interferon alpha therapy of chronic hepatitis D: regression of advanced hepatic fibrosis.

1 reference

7 January 2021

The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial

1 reference

7 January 2021

Treatment of chronic hepatitis D with thymus-derived polypeptide thymic humoral factor-gamma 2: a pilot study

1 reference

7 January 2021

Famciclovir treatment of chronic delta hepatitis

1 reference

7 January 2021

Lamivudine therapy in chronic delta hepatitis: a multicentre randomized-controlled pilot study

1 reference

7 January 2021

Ribavirin treatment for chronic hepatitis D: a pilot study.

1 reference

7 January 2021

Radioimmunoassay detection of IgM antibodies to the HBV-associated delta (delta) antigen:" clinical significance in delta infection

1 reference

7 January 2021

Hepatitis D viremia following orthotopic liver transplantation involves a typical HDV virion with a hepatitis B surface antigen envelope.

1 reference

7 January 2021

Pathologic features of chronic hepatitis. A review and update

1 reference

7 January 2021

Loss of HBsAg with interferon-alpha therapy in chronic hepatitis D virus infection

1 reference

7 January 2021

Antiviral therapy of HBV- and HCV-induced liver cirrhosis

1 reference

7 January 2021

Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP)

1 reference

7 January 2021

Nonresponders to hepatitis C virus antiviral therapy: pegylated interferons and beyond

1 reference

7 January 2021

Clearance of hepatitis B surface antigen in chronic carriers of hepatitis delta antibodies.

1 reference

7 January 2021

Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21296

1 reference

15 March 2018

1 reference

15 March 2018